Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin-Reference-Cited by-同舟云学术

Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin

Published:2016-08-16 Issue:41 Volume:7 Page:67495-67506
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Overman Michael J.¹,Morris Van¹,Moinova Helen²,Manyam Ganiraju³,Ensor Joe⁴,Lee Michael S.⁵,Eng Cathy¹,Kee Bryan¹,Fogelman David¹,Shroff Rachna T.¹,LaFramboise Thomas⁶,Mazard Thibault¹,Feng Tian¹,Hamilton Stanley⁷,Broom Bradley³,Lutterbaugh James²,Issa Jean-Pierre⁸,Markowitz Sanford D.²,Kopetz Scott¹

Affiliation:

1. Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

2. Department of Medicine and Case Comprehensive Cancer Center, Case Western Reserve University and Case Medical Center, Cleveland, OH, USA

3. Department of Bioinformatics and Computational Biology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

4. Houston Methodist Cancer Center, Houston Methodist Research Institute, Houston, TX, USA

5. Division of Hematology/Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA

6. Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA

7. Division of Pathology and Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

8. Fels Institute for Cancer and Molecular Biology, Temple University, Philadelphia, PA, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA methylation modulates epigenetic regulation in colorectal cancer diagnosis, prognosis and precision medicine;Exploration of Targeted Anti-tumor Therapy;2024-01-28

2. DNMT1 expression partially dictates 5-Azacytidine sensitivity and correlates with RAS/MEK/ERK activity in gastric cancer cells;Epigenetics;2023-09-10

3. T Cells in Colorectal Cancer: Unravelling the Function of Different T Cell Subsets in the Tumor Microenvironment;International Journal of Molecular Sciences;2023-07-19

4. A randomized, phase II trial of oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence;Clinical Epigenetics;2022-12

5. Bintrafusp Alfa, an Anti-PD-L1:TGFβ Trap Fusion Protein, in Patients with ctDNA-positive, Liver-limited Metastatic Colorectal Cancer;Cancer Research Communications;2022-09-14